Important Considerations in Modeling the Cost-Effectiveness for the First Food and Drug Administration-Approved Gene Therapy and Implications for F... - PubMed - NCBI

Important Considerations in Modeling the Cost-Effectiveness for the First Food and Drug Administration-Approved Gene Therapy and Implications for F... - PubMed - NCBI

Value Health. 2019 Aug;22(8):970-971. doi: 10.1016/j.jval.2018.12.013. Epub 2019 May 25.

Important Considerations in Modeling the Cost-Effectiveness for the First Food and Drug Administration-Approved Gene Therapy and Implications for Future One-Time Therapies.

Buessing M1, O'Connell T1, Johnson S1, Pitluck S2, Ciulla TA2.

Author information

1

Medicus Economics, Boston, MA, USA.

2

Spark Therapeutics, Philadelphia, PA, USA.

PMID:

 

31426938

 

DOI:

 

10.1016/j.jval.2018.12.013